𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients

✍ Scribed by Claire J Searle, Ian W Brock, Simon S Cross, Sabapathy P Balasubramanian…

Book ID
120797999
Publisher
Springer
Year
2012
Tongue
English
Weight
388 KB
Volume
1
Category
Article
ISSN
2193-1801

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory BCL2 promoter polymorphism (−
Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma
✍ Hagen S. Bachmann; Lukas C. Heukamp; Klaus J. Schmitz; Caroline F. Hilburn; Phil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 539 KB

## Abstract Molecular markers predictive of prostate cancer prognosis are urgently needed. Overexpression of the antiapoptotic protein, Bcl‐2, has repeatedly been shown to be associated with adverse outcome in this malignancy. We hypothesized that a regulatory __BCL2__ −938C>A promoter polymorphism

High expression of 90K (Mac-2 BP) is ass
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies
✍ Nicola Tinari; Rossano Lattanzio; Patrizia Querzoli; Clara Natoli; Antonino Gras 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 234 KB

## Abstract 90K (Mac‐2 BP) expression was evaluated by immunohistochemistry in paraffin‐embedded tissue from a consecutive series of lymph‐node negative breast cancer patients who did not receive adjuvant systemic treatment. An independent series of patients served as validation set. The associatio